Review



irisin inhibitor rgds  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    MedChemExpress irisin inhibitor rgds
    Irisin down-regulates PIAS4 to repress EHMT2 SUMOylation, thereby promoting osteogenic differentiation. MSCs were infected with lentivirus containing oe-NC or oe-PIAS4 with or without irisin together. A Osteogenic differentiation potential was evaluated by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). B Western blotting analysis of protein levels of PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1. (C) Cells were lysed and immunoprecipitated with EHMT2 antibody and then immunoblotted with SUMO2/3 or EHMT2 antibody. MSCs were treated with irisin together with or without <t>irisin</t> <t>inhibitor</t> <t>RGDS.</t> (D) Osteogenic differentiation potential was determined by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). (E) The protein levels of FAK, p-FAK, SKP2, PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1 were assessed by Western blotting. (F) Cell lysates were immunoprecipitated with EHMT2 antibody, followed by immunoblotting with SUMO2/3 or EHMT2 antibody. (G) Ubiquitin level of EHMT2 was analyzed by Co-IP. n = 3. One-way ANOVA (for B, E) was performed for statistical analysis. * p < 0.05, ** p < 0.01, *** p < 0.001
    Irisin Inhibitor Rgds, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 13 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/irisin inhibitor rgds/product/MedChemExpress
    Average 94 stars, based on 13 article reviews
    irisin inhibitor rgds - by Bioz Stars, 2026-02
    94/100 stars

    Images

    1) Product Images from "Down-regulation of EHMT2 through irisin-mediated epigenetic modification promotes osteogenesis via promoting DLX3 transcription"

    Article Title: Down-regulation of EHMT2 through irisin-mediated epigenetic modification promotes osteogenesis via promoting DLX3 transcription

    Journal: Cell Communication and Signaling : CCS

    doi: 10.1186/s12964-025-02463-x

    Irisin down-regulates PIAS4 to repress EHMT2 SUMOylation, thereby promoting osteogenic differentiation. MSCs were infected with lentivirus containing oe-NC or oe-PIAS4 with or without irisin together. A Osteogenic differentiation potential was evaluated by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). B Western blotting analysis of protein levels of PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1. (C) Cells were lysed and immunoprecipitated with EHMT2 antibody and then immunoblotted with SUMO2/3 or EHMT2 antibody. MSCs were treated with irisin together with or without irisin inhibitor RGDS. (D) Osteogenic differentiation potential was determined by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). (E) The protein levels of FAK, p-FAK, SKP2, PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1 were assessed by Western blotting. (F) Cell lysates were immunoprecipitated with EHMT2 antibody, followed by immunoblotting with SUMO2/3 or EHMT2 antibody. (G) Ubiquitin level of EHMT2 was analyzed by Co-IP. n = 3. One-way ANOVA (for B, E) was performed for statistical analysis. * p < 0.05, ** p < 0.01, *** p < 0.001
    Figure Legend Snippet: Irisin down-regulates PIAS4 to repress EHMT2 SUMOylation, thereby promoting osteogenic differentiation. MSCs were infected with lentivirus containing oe-NC or oe-PIAS4 with or without irisin together. A Osteogenic differentiation potential was evaluated by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). B Western blotting analysis of protein levels of PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1. (C) Cells were lysed and immunoprecipitated with EHMT2 antibody and then immunoblotted with SUMO2/3 or EHMT2 antibody. MSCs were treated with irisin together with or without irisin inhibitor RGDS. (D) Osteogenic differentiation potential was determined by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). (E) The protein levels of FAK, p-FAK, SKP2, PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1 were assessed by Western blotting. (F) Cell lysates were immunoprecipitated with EHMT2 antibody, followed by immunoblotting with SUMO2/3 or EHMT2 antibody. (G) Ubiquitin level of EHMT2 was analyzed by Co-IP. n = 3. One-way ANOVA (for B, E) was performed for statistical analysis. * p < 0.05, ** p < 0.01, *** p < 0.001

    Techniques Used: Infection, Staining, Western Blot, Immunoprecipitation, Ubiquitin Proteomics, Co-Immunoprecipitation Assay



    Similar Products

    irisin inhibitor rgds  (MedChemExpress)
    94
    MedChemExpress irisin inhibitor rgds
    Irisin down-regulates PIAS4 to repress EHMT2 SUMOylation, thereby promoting osteogenic differentiation. MSCs were infected with lentivirus containing oe-NC or oe-PIAS4 with or without irisin together. A Osteogenic differentiation potential was evaluated by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). B Western blotting analysis of protein levels of PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1. (C) Cells were lysed and immunoprecipitated with EHMT2 antibody and then immunoblotted with SUMO2/3 or EHMT2 antibody. MSCs were treated with irisin together with or without <t>irisin</t> <t>inhibitor</t> <t>RGDS.</t> (D) Osteogenic differentiation potential was determined by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). (E) The protein levels of FAK, p-FAK, SKP2, PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1 were assessed by Western blotting. (F) Cell lysates were immunoprecipitated with EHMT2 antibody, followed by immunoblotting with SUMO2/3 or EHMT2 antibody. (G) Ubiquitin level of EHMT2 was analyzed by Co-IP. n = 3. One-way ANOVA (for B, E) was performed for statistical analysis. * p < 0.05, ** p < 0.01, *** p < 0.001
    Irisin Inhibitor Rgds, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/irisin inhibitor rgds/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    irisin inhibitor rgds - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Irisin down-regulates PIAS4 to repress EHMT2 SUMOylation, thereby promoting osteogenic differentiation. MSCs were infected with lentivirus containing oe-NC or oe-PIAS4 with or without irisin together. A Osteogenic differentiation potential was evaluated by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). B Western blotting analysis of protein levels of PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1. (C) Cells were lysed and immunoprecipitated with EHMT2 antibody and then immunoblotted with SUMO2/3 or EHMT2 antibody. MSCs were treated with irisin together with or without irisin inhibitor RGDS. (D) Osteogenic differentiation potential was determined by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). (E) The protein levels of FAK, p-FAK, SKP2, PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1 were assessed by Western blotting. (F) Cell lysates were immunoprecipitated with EHMT2 antibody, followed by immunoblotting with SUMO2/3 or EHMT2 antibody. (G) Ubiquitin level of EHMT2 was analyzed by Co-IP. n = 3. One-way ANOVA (for B, E) was performed for statistical analysis. * p < 0.05, ** p < 0.01, *** p < 0.001

    Journal: Cell Communication and Signaling : CCS

    Article Title: Down-regulation of EHMT2 through irisin-mediated epigenetic modification promotes osteogenesis via promoting DLX3 transcription

    doi: 10.1186/s12964-025-02463-x

    Figure Lengend Snippet: Irisin down-regulates PIAS4 to repress EHMT2 SUMOylation, thereby promoting osteogenic differentiation. MSCs were infected with lentivirus containing oe-NC or oe-PIAS4 with or without irisin together. A Osteogenic differentiation potential was evaluated by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). B Western blotting analysis of protein levels of PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1. (C) Cells were lysed and immunoprecipitated with EHMT2 antibody and then immunoblotted with SUMO2/3 or EHMT2 antibody. MSCs were treated with irisin together with or without irisin inhibitor RGDS. (D) Osteogenic differentiation potential was determined by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). (E) The protein levels of FAK, p-FAK, SKP2, PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1 were assessed by Western blotting. (F) Cell lysates were immunoprecipitated with EHMT2 antibody, followed by immunoblotting with SUMO2/3 or EHMT2 antibody. (G) Ubiquitin level of EHMT2 was analyzed by Co-IP. n = 3. One-way ANOVA (for B, E) was performed for statistical analysis. * p < 0.05, ** p < 0.01, *** p < 0.001

    Article Snippet: MSCs were treated with 100 ng/mL irisin (MCE, NJ, USA) together with or without irisin inhibitor RGDS (100 nM, MCE) for 48 h.

    Techniques: Infection, Staining, Western Blot, Immunoprecipitation, Ubiquitin Proteomics, Co-Immunoprecipitation Assay